ARYA Sciences Announces Shareholder Approval of Combination
by Kristi Marvin on 2020-06-29 at 5:03pm

ARYA Sciences Acquisition Corp. (ARYA) announced by press release this afternoon that their combination with Immatics Biotechnologies GmbH has been approved. The shares of common stock and warrants are expected to begin trading under the tickers (IMTX) and (IMTXW).

Additionally, none of the shareholders elected to redeem their shares in connection with the shareholder vote.  But this was expected since ARYA’s share price has been trading at roughly $16.77, well above estimated trust value. Nonetheless, this is a strong result.

Backed by Perceptive Advisors, one of the most well known life sciences hedge funds, ARYA’s combination with Immatics looked like a well received combination when it was announced in March 2020 and expectations for success have only gained steam since then.

This transaction is expected to close in the coming few days.


ADVISORS

  • Goldman Sachs International and SVB Leerink are acting as lead financial advisors.
  • BofA Securities and Kempen are serving as financial advisors to Immatics.
  • Jefferies LLC is acting as lead financial and capital markets advisor to Arya as well as sole private placement agent.
  • Chardan Capital Markets LLC is also serving as advisor to Arya.
  • Goodwin Procter LLP and CMS Legal Services EEIG are acting as legal counsel to Immatics.
  • Kirkland & Ellis LLP is serving as legal counsel to Arya.

 

 

Recent Posts
by Kristi Marvin on 2024-04-20 at 11:45am

Terms Tracker for the Week Ending April 19, 2024 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Passover and school spring break starts next week, which most likely means a slowdown in SPAC filing activity. Although Churchill IX is now rumored to...

by Nicholas Alan Clayton on 2024-04-19 at 3:00pm

Despite a week of general pull-backs in the market, fintech firm Ibotta (NYSE:IBTA) nonetheless took the dive and had a good week debuting via a traditional IPO in the choppy waters. The company, which provides app-based consumer cashback discounts on purchases, priced its IPO at $88, above its proposed range of $76 to $84, and...

by Nicholas Alan Clayton on 2024-04-19 at 7:53am

At the SPAC of Dawn Happy Friday! SPACInsider has unveiled new presets on SPAC Performance accessible via the Data drop-down to easily sort for the highest and lowest performing active SPACs and de-SPACs. On the de-SPAC side, Vertiv (NYSE:VRT) continues to be well ahead of the pack, logging a 710% return by share price adjusted...

by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved